InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Tuesday, 02/12/2019 2:53:24 PM

Tuesday, February 12, 2019 2:53:24 PM

Post# of 43747
The consequences of a trial on overall survival -like this one- which lasts longer than expected are more extreme phase 3 results:
OR the beneficial effect of MK+SOC vs SOC is 5% or lower
OR the beneficial effect of MK+SOC vs SOC is 25-50%

Because we have well documented statistics on overall survival of stages 3 and 4a of H&N Cancer, I think we could be very surprised in a good way once the results are announced.

Remember: Companies cannot fake/fraud tumor shrinkage/elimination.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News